Welcome to our dedicated page for Nephros news (Ticker: NEPH), a resource for investors and traders seeking the latest updates and insights on Nephros stock.
Nephros Inc. reports developments in water technology for medical and commercial markets, with emphasis on point-of-use filtration, waterborne pathogen risk reduction, and water management support. Company news commonly covers quarterly financial results, programmatic revenue trends, service offerings, customer education, and product adoption across healthcare facilities and other complex buildings.
Updates also include expansions of Nephros' water safety capabilities, regional market initiatives, and the Nephros Water Institute, an education effort focused on water quality, infection prevention, regulatory readiness, and emergency preparedness for compromised water events.
Nephros (Nasdaq: NEPH) reported record second-quarter 2026 net revenue of $6.0 million, up 36% from $4.4 million in 2025, with core programmatic revenue growing 27% year over year. Net income rose to $1.2 million from $0.2 million, including an approximately $0.6 million one-time tariff refund benefit.
Gross margin improved to 67% from 63%, aided by recognizing the IEEPA tariff refund as a reduction of cost of goods sold. Adjusted EBITDA increased to $1.3 million from $0.4 million. For the first six months of 2026, revenue was $11.2 million (up 21%), net income $1.3 million, and Adjusted EBITDA $1.5 million. According to Nephros, cash and equivalents were $4.7 million as of June 30, 2026, and the company remained debt free.
Nephros (Nasdaq: NEPH) will file its second quarter 2026 financial results on Thursday, August 06, 2026 after market close and host a conference call at 4:30 p.m. ET the same day. Domestic and international dial-in numbers and replay details, including access code 3951894, are provided.
Nephros (Nasdaq: NEPH), a water technology and filtration company, announced its inclusion in the Russell Microcap® Index following the 2026 annual reconstitution. Membership became effective after the US market close on June 26, 2026 and will remain in place for one year.
Inclusion also provides automatic membership in the appropriate Russell growth and value style indexes, with FTSE Russell determining index membership based mainly on market-capitalization rankings and style attributes. Nephros’ CEO stated the company believes this may support long-term shareholder value and increase visibility with potential institutional and other new investors.
Nephros (Nasdaq: NEPH) will host a virtual investor event, “Beyond Filtration: The Nephros Model in Action,” on July 16, 2026 at 12:00 PM EST. The program will showcase its scalable, service-driven water safety model and feature field leaders, partners, and Nephros Water Institute leadership.
Nephros (Nasdaq:NEPH), a water technology company, highlighted its ultrafiltration as a solution for emerging microplastic and nanoplastic risks in drinking water.
The update follows the U.S. EPA’s April 2026 move to list microplastics as a priority contaminant group under draft CCL 6.
Nephros (Nasdaq: NEPH) reported Q1 2026 results: net revenue $5.2M (up 7% YoY) and net income $0.14M. Core programmatic revenue rose 23% YoY. Gross margin fell to 57% from 65% due to tariffs, FX headwinds, and revenue mix shifts. Cash was ~$4.0M; company remains debt free.
Nephros (Nasdaq: NEPH) will file first-quarter 2026 financial results on Thursday, May 7, 2026 after market close and will host a conference call the same day at 4:30 PM ET.
Dial-in numbers, an audio archive on the Nephros investor relations page, and a replay available through May 14, 2026 (replay code 1329051) were provided.
Nephros (Nasdaq: NEPH) is expanding its Greater New York market focus by hiring Dana Cunningham as a dedicated regional sales leader, effective April 16, 2026. The company cites a $25 million annual addressable opportunity for point-of-use filtration and related services in the region.
Cunningham will target healthcare systems, commercial facilities, and channel partners to accelerate adoption of Nephros’ filtration solutions amid aging infrastructure, heightened regulatory focus, and elevated waterborne pathogen risk.
Nephros (Nasdaq: NEPH) announced an expansion of customer-facing water-safety services on April 1, 2026, after Brianne McGuire earned the ASSE 12080 Legionella Water Safety and Management Specialist certification.
The company will now offer consultative Water Management Program (WMP) development services alongside filtration product installations, training and public education, and expects the capability to add customer value and a chargeable consulting revenue stream.
Nephros (Nasdaq: NEPH) reported fiscal 2025 results with net revenue $18.8M (up 33% YoY) and fourth-quarter revenue of $4.7M (up 22% YoY). The company reported net income $1.2M and Adjusted EBITDA $1.6M for 2025, and ended the year with $5.4M cash and no debt.
Gross margin held at 62% for the year; Q4 margin compressed to 58% due largely to tariffs on imports from Italy (15% since April 2025, reduced to 10% Feb 22, 2026). Company cites growth from programmatic reorders, emergency response, service expansion, and a new Nephros Water Institute.